<SEC-DOCUMENT>0001213900-25-017089.txt : 20250225
<SEC-HEADER>0001213900-25-017089.hdr.sgml : 20250225
<ACCEPTANCE-DATETIME>20250225161531
ACCESSION NUMBER:		0001213900-25-017089
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250221
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250225
DATE AS OF CHANGE:		20250225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			180 Life Sciences Corp.
		CENTRAL INDEX KEY:			0001690080
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				813832378
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38105
		FILM NUMBER:		25663419

	BUSINESS ADDRESS:	
		STREET 1:		3000 EL CAMINO REAL
		STREET 2:		BLDG 4, STE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306
		BUSINESS PHONE:		650-507-0669

	MAIL ADDRESS:	
		STREET 1:		3000 EL CAMINO REAL
		STREET 2:		BLDG 4, STE 200
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94306

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KBL MERGER CORP. IV
		DATE OF NAME CHANGE:	20161115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea023200801-8k_180life.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ATNF="http://180lifesciencescorp.com/20250221">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_ATNF_180lifesciencescorp.com_20250221 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20250221_20250221 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001690080 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000004" name="dei:EntityCentralIndexKey">0001690080</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="atnf-20250221.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-02-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-21</xbrli:startDate>
        <xbrli:endDate>2025-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-21</xbrli:startDate>
        <xbrli:endDate>2025-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001690080</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:WarrantsToPurchaseSharesOfCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-21</xbrli:startDate>
        <xbrli:endDate>2025-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>FORM&#160;<span id="xdx_906_edei--DocumentType_c20250221__20250221_zl7wXe5hlR9j"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>PURSUANT TO SECTION 13
OR 15(d) OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>SECURITIES EXCHANGE ACT
OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">Date of Report (Date of earliest
event reported):&#160;<b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20250221__20250221_zor0VqooED5d"><ix:nonNumeric contextRef="AsOf2025-02-21" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">February 21, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_904_edei--EntityRegistrantName_c20250221__20250221_zadYyvWvCVxd"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000011" name="dei:EntityRegistrantName">180 LIFE SCIENCES CORP.</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">(Exact Name of Registrant
as Specified in Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20250221__20250221_zNOU455y5zaf"><ix:nonNumeric contextRef="AsOf2025-02-21" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20250221__20250221_zWNEGlEpid4a"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000013" name="dei:EntityFileNumber">001-38105</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20250221__20250221_z7yEjLJYWFrf"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000014" name="dei:EntityTaxIdentificationNumber">90-1890354</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction<br/>
of Incorporation)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(IRS Employer<br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 50%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20250221__20250221_zbGtNM5OkA2g"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000015" name="dei:EntityAddressAddressLine1">3000 El Camino Real</ix:nonNumeric></span>,<span id="xdx_904_edei--EntityAddressAddressLine2_c20250221__20250221_znltFCxI1xU4"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000016" name="dei:EntityAddressAddressLine2">&#160;Bldg. 4</ix:nonNumeric></span>,<span id="xdx_902_edei--EntityAddressAddressLine3_c20250221__20250221_zkVQEfIT1lFh"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000017" name="dei:EntityAddressAddressLine3">&#160;Suite 200</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_909_edei--EntityAddressCityOrTown_c20250221__20250221_zGQM6KltYUvj"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000018" name="dei:EntityAddressCityOrTown">Palo Alto</ix:nonNumeric></span>,&#160;<span id="xdx_908_edei--EntityAddressStateOrProvince_c20250221__20250221_zw08X10WCeDj"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000019" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20250221__20250221_zFjQUGM2h4gf"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000020" name="dei:EntityAddressPostalZipCode">94306</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Address of Principal Executive Offices)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">Registrant&#8217;s telephone
number, including area code:&#160;<b><span style="text-decoration: underline"><span id="xdx_90F_edei--CityAreaCode_c20250221__20250221_z3NSOxeJL9pj"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000021" name="dei:CityAreaCode">(650)</ix:nonNumeric></span>&#160;<span id="xdx_904_edei--LocalPhoneNumber_c20250221__20250221_z79WiR77HUYf"><ix:nonNumeric contextRef="AsOf2025-02-21" id="Fact000022" name="dei:LocalPhoneNumber">507-0669</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (<i>see&#160;</i>General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.15pt; text-align: justify; text-indent: -0.15pt; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--WrittenCommunications_c20250221__20250221_zOQLSGjhywK5"><ix:nonNumeric contextRef="AsOf2025-02-21" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20250221__20250221_zID4tuLbUZO"><ix:nonNumeric contextRef="AsOf2025-02-21" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--PreCommencementTenderOffer_c20250221__20250221_zOf4jYchSRmf"><ix:nonNumeric contextRef="AsOf2025-02-21" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20250221__20250221_zyvN6YYzcOok"><ix:nonNumeric contextRef="AsOf2025-02-21" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Securities registered pursuant
to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 34%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="white-space: nowrap; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20250221__20250221__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zzsBYOsqvMY4"><ix:nonNumeric contextRef="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember" id="Fact000027" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20250221__20250221__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_znllgVy6FHe3"><ix:nonNumeric contextRef="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember" id="Fact000028" name="dei:TradingSymbol">ATNF</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The&#160;<span id="xdx_90C_edei--SecurityExchangeName_c20250221__20250221__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zNmKBXCPH1m5"><ix:nonNumeric contextRef="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>&#160;Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20250221__20250221__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_zxkcJcnP4jGa"><ix:nonNumeric contextRef="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember" id="Fact000030" name="dei:Security12bTitle">Warrants to purchase shares of Common Stock</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20250221__20250221__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_z7EWEjwDnYc4"><ix:nonNumeric contextRef="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember" id="Fact000031" name="dei:TradingSymbol">ATNFW</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">The&#160;<span id="xdx_901_edei--SecurityExchangeName_c20250221__20250221__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseSharesOfCommonStockMember_ziBuy1telqFf"><ix:nonNumeric contextRef="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember" format="ixt-sec:exchnameen" id="Fact000032" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>&#160;Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Emerging growth company&#160;<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20250221__20250221_z5bqU8sc3Xb3"><ix:nonNumeric contextRef="AsOf2025-02-21" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo --><!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 1.01 Entry into a Material Definitive Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On February
21, 2025, 180 Life Sciences Corp. (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;) entered into a Mutual Settlement and General Release Agreement with
Dr. Marlene Krauss (&#8220;<span style="text-decoration: underline">Dr. Krauss</span>&#8221;), the former Chief Executive Officer and director of KBL Merger Corp. IV, the Company&#8217;s
predecessor, and KBL IV Sponsor, LLC (&#8220;<span style="text-decoration: underline">KBL Sponsor</span>&#8221;) (the &#8220;<span style="text-decoration: underline">Settlement Agreement</span>&#8221;). Pursuant to the
Settlement Agreement, the Company agreed to (1) pay $50,000 within twenty days from February 21, 2025 (the &#8220;<span style="text-decoration: underline">Cash Payment</span>&#8221;),
and (2) issue 200,000 shares of restricted common stock within three business days (the &#8220;<span style="text-decoration: underline">Settlement Shares</span>&#8221;). The Settlement
Shares include piggyback registration rights for a resale registration statement relative to the Settlement Shares for a period of six
(6) months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Settlement
Agreement also required Dr. Krauss to enter into a Voting Agreement with the Company. Pursuant to the Voting Agreement, which was entered
into on February 21, 2025, by Dr. Krauss, the Company, and Blair Jordan, the Company&#8217;s Chief Executive Officer, solely for the benefit
of the Company, Dr. Krauss agreed to vote the Settlement Shares as recommended by the Board of Directors of the Company, at any meeting
of stockholders or via any written consent of stockholders, which may occur prior to August 21, 2025. In order to enforce the terms of
the Voting Agreement, and solely for the benefit of the Company, Dr. Krauss provided Mr. Jordan (or his assigns) an irrevocable voting
proxy to vote the Settlement Shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent
of stockholders. The Voting Agreement also provides a restriction on Dr. Krauss&#8217;s sale or transfer of any of the Settlement Shares
until August 21, 2025 and provides for mutual general releases of the parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The Settlement
Agreement requires Dr. Krauss to file a dismissal of her court actions within ten days after receipt of the Cash Payment and that the
Company, Dr. Krauss and KBL Sponsor dismiss all of their claims against one another with prejudice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the Settlement
Agreement and Voting Agreement is a summary only and is qualified in its entirety by reference to the Settlement Agreement and Voting
Agreement, copies of which are attached hereto (or incorporated by reference herein)&#160;as&#160;<span style="text-decoration: underline">Exhibits 10.1</span>&#160;and&#160;<span style="text-decoration: underline">10.2</span>,
respectively and are incorporated into this&#160;<span style="text-decoration: underline">Item 1.01</span>&#160;by reference in its entirety.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Item 3.02 Unregistered Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The information
contained above in <span style="text-decoration: underline">Item 1.01</span> related to the Settlement Shares is hereby incorporated by reference into this <span style="text-decoration: underline">Item 3.02</span>. The
Settlement Shares were issued without registration under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;),
in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering and in
reliance on similar exemptions under applicable state laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Item 9.01 Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>(d) Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 8%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 91%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt">10.1*</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="ea023200801ex10-1_180life.htm">Mutual Settlement and General Release Agreement dated February 21, 2025, between 180 Life Sciences Corp., Marlene Krauss, and KBL IV Sponsor, LLC</a></span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top"><span style="font-size: 10pt">10.2*</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt"><a href="ea023200801ex10-2_180life.htm">Voting Agreement dated February 21, 2025, between 180 Life Sciences Corp., Dr. Marlene Krauss and Blair Jordan</a></span></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt">*</span></td>
    <td style="width: 99%; text-align: justify"><span style="font-size: 10pt">Filed herewith.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>180 LIFE SCIENCES CORP.</b></span></td></tr>
  <tr>
    <td style="width: 62%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: February 25, 2025</span></td>
    <td><span style="font-size: 10pt">By:&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Blair Jordan</i></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Blair Jordan</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kUFuwjAQRU/AHUZRl4g6rthk10YUVYU2ChFla8KkWCSeaOxQOFJvWccBlUVrjWRZM+//P3IUjaM5PesaGTZP+QIKbNpaOYQcK2Q0JfqJ9OU1AX/n+KmtY2VceF7BlDyDnplO5HTrG2H0qC3uEhDyXk59QSyTBwHZMhr1/ZRMpXdonFY1KLODjKlljU7xeVAo1IkMNedgtUa2mkwC8UQM7W+QIpbwRkf1RXywsFik0WgcziiaM3Wtn5qdHJqehFmNjbezA/1bIU3ZWUdN8qG4X84WlHVc7pXF1V4x2vfKr9iQWTkqD0tstsgeioWUsXi85Lmy4AjaCw024EAVDAIQFP5wvtHPFK9V3aGYCCHiDDlk+Mf1VnYMrWI49izcDTS0/ntCiKvnD2fxlgI= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea023200801ex10-1_180life.htm
<DESCRIPTION>MUTUAL SETTLEMENT AND GENERAL RELEASE AGREEMENT DATED FEBRUARY 21, 2025, BETWEEN 180 LIFE SCIENCES CORP., MARLENE KRAUSS, AND KBL IV SPONSOR, LLC
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
10.1</font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><u>MUTUAL
SETTLEMENT AND GENERAL RELEASE AGREEMENT</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Mutual Settlement and General Release Agreement (the &quot;Agreement&quot;) is made and entered into by and between (1) 180 LIFE SCIENCES
CORP. (&ldquo;180 Life&rdquo;), on the one hand, and (2) MARLENE KRAUSS (&ldquo;Dr. Krauss&rdquo;), and (3) KBL IV SPONSOR, LLC (&ldquo;KBL
Sponsor&rdquo;) [hereinafter, Dr. Krauss and KBL Sponsor sometimes collectively referred to as the &ldquo;Krauss Parties&rdquo;], on
the other hand (hereinafter, 180 Life and the Krauss Parties sometimes collectively referred to as &ldquo;the Parties&rdquo;, and individually
as a &ldquo;Party&rdquo;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>RECITALS</u></b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made with reference to the following facts and for the following purpose:</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.&nbsp;On
or about August 19, 2021, Dr. Krauss filed a Complaint (the &ldquo;Advancement Complaint&rdquo;) and commenced a legal action against
180 Life in the Chancery Court of Delaware (the &ldquo;Delaware Court&rdquo;) entitled <i>Marlene Krauss, M.D. v. 180 Life Sciences Corp.</i>,
Case No. 2021-0714-LWW (the &ldquo;Advancement Action&rdquo;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.&nbsp;On
or about September 1, 2021, 180 Life filed a Complaint (the &ldquo;Claims Complaint&rdquo;) and commenced a legal action against Dr.
Krauss, KBL Sponsor and KBL Healthcare Management, Inc. (&ldquo;KBL Healthcare&rdquo;) in the Delaware Court entitled <i>180 Life Sciences
Corp. v. Marlene Krauss, et al.</i>, Case No. 2021-0754-LWW (the &ldquo;Claims Action&rdquo;).</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.&nbsp;On
or about September 3, 2021, in the Advancement Action, Dr. Krauss filed an Amended and Supplemental Complaint (the &ldquo;Amended Advancement
Complaint&rdquo;) against 180 Life, which 180 Life subsequently answered and denied.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.&nbsp;On
or about October 5, 2021, in the Claims Action, the Krauss Parties filed an Answer, Counterclaims and Third-Party Complaint (the &ldquo;Initial
Counterclaims&rdquo;) against 180 Life and twelve third party defendant former directors and/or officers of 180 Life, <i>i.e</i>., Marc
Feldmann (&ldquo;Feldmann&rdquo;), Lawrence Steinman (&ldquo;Steinman&rdquo;), James N. Woody (&ldquo;Woody&rdquo;),&nbsp;Teresa&nbsp;DeLuca
(&ldquo;DeLuca&rdquo;), Frank Knuettel II (&ldquo;Knuettel&rdquo;), Pamela Marrone (&ldquo;Marrone&rdquo;), Lawrence Gold (&ldquo;Gold&rdquo;),
Donald A. McGovern, Jr. (&ldquo;McGovern&rdquo;), Russell T. Ray (&ldquo;Ray&rdquo;), Richard W. Barker (&ldquo;Barker&rdquo;), Shoshana
Shendelman (&ldquo;Shendelman&rdquo;) and Ozan Pamir (&ldquo;Pamir&rdquo;) [collectively, the &ldquo;Third Party Defendants&rdquo;].</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.&nbsp;On
or about February 24, 2022, in the Claims Action, the Krauss Parties dismissed DeLuca, Knuettel, Marrone, Ray, Barker and Shendelman,
and filed an amended Answer, Counterclaims and Third-Party Complaint against 180 Life and Feldmann, Steinman, Woody,&nbsp;Gold, McGovern
and Pamir (the &ldquo;Amended Counterclaims&rdquo;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.&nbsp;On
or about April 19, 2022, the Krauss Parties dismissed Gold and McGovern from the Amended Counterclaims. 180 Life, Feldmann, Steinman,
Woody and Pamir answered and denied the Amended Counterclaims.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.&nbsp;On
or about May 3, 2023, the Delaware Court in the Advancement Action issued an Order granting certain applications by Dr. Krauss and requiring
180 Life to make certain advance payments to Dr. Krauss (the &ldquo;Advancement Order&rdquo;). Subsequent thereto, Dr. Krauss posted
an undertaking in this regard (the &ldquo;Undertaking&rdquo;), and 180 Life made a series of advance monetary payments to Dr. Krauss
(collectively, the &ldquo;Advance Payments&rdquo;).</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.&nbsp;The
purpose of this Agreement is for the Parties to completely settle their differences, and, except as may otherwise be provided for herein,
for the Parties to generally release each other and the other persons set forth below from any and all liabilities, claims, defenses,
causes of action, damages, costs or demands, including without limitation, those which arise out of or are in any way connected with
the Advancement Complaint, Amended Advancement Complaint, Claims Complaint, the Initial Counterclaims, the Amended Counterclaims, the
Advancement Order, the Undertaking, the Advance Payments, the Advancement Action and/or the Claims Action.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>AGREEMENT</u></b></font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, the Parties, and each of them, hereby warrant, represent, acknowledge, and agree as follows:</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 1in"></td><td style="text-align: justify; width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Payment
                                            By 180 Life To Dr. Krauss</u>.</b></font></td></tr></table>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-indent: -0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;Within
twenty (20) days from the &ldquo;Effective Date&rdquo; (defined below in paragraph 24) of this Agreement, 180 Life shall pay to Dr. Krauss
the total sum of $50,000.00 (the &ldquo;Settlement Sum&rdquo;). If the due date for payment of the Settlement Sum falls on a weekend
or a legal holiday, such payment shall be deemed to be due on the first business day thereafter.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Courier; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&nbsp;Time
is of the essence in this Agreement, and payment of the Settlement Sum as referred to in paragraph 1 above shall be due on the date upon
which such payment shall be made. The payment required by paragraph 1 above shall be timely made by wire transfer instructions to be
separately provided in writing between respective counsel for the Parties.</font></p>

<p style="font: 10pt Courier; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Courier; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Courier; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 1in"></td><td style="text-align: justify; width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>180
                                            Life Issuance Of Shares To Dr. Krauss; Voting Support Agreement; Piggyback Registration And
                                            Rule 144 Legal Opinion; Antidilution</u>.</b></font></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&nbsp;Within
three (3) business days of the Effective Date of this Agreement, 180 Life shall issue to Dr. Krauss $250,000.00 worth of 180 Life shares
of common stock (the &ldquo;Subject Shares&rdquo;), with the value of the Subject Shares being calculated and based on the closing sales
price of 180 Life&rsquo;s common stock on the Effective Date of the Agreement (or if the Effective Date is not a trading day, the last
trading day prior to the Effective Date). Dr. Krauss hereby pledges and affirms that, in the event of any shareholder vote for a period
of six (6) months following the Effective Date of this Agreement, Dr. Krauss will support and vote in favor of any proposal which the
Board of Directors of 180 Life bring to shareholders of 180 Life. This will be reflected in a Voting Agreement to be executed within
ten days of the Effective Date of this Agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&nbsp;180
Life will provide Dr. Krauss with piggyback registration rights for a resale registration statement relative to the Subject Shares for
a period of six (6) months, excluding Form S-8s, Form S-4s, and the resale registration statement currently in process with Armistice
and other institutional investors, and will provide Dr. Krauss with a Rule 144 legal opinion at 180 Life&rsquo;s expense which will allow
the Subject Shares to be sold after six (6) months.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Subject Shares shall have anti-dilution protections in place, <i>i.e</i>., the Subject Shares shall be subject to adjustment for reverse
and forward stock splits, stock dividends, and stock combinations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 1in"></td><td style="text-align: justify; width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Dismissal
                                            Of The Advancement Action And The Claims Action With Prejudice</u>.</b></font></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&nbsp;Within
ten (10) days after delivery of the Settlement Sum to Dr. Krauss: (a) the attorneys of record for Dr. Krauss shall file a dismissal of
the entirety of the Advancement Action with prejudice with the Delaware Court; and (b) the respective attorneys of record for both 180
Life and the Krauss Parties shall file a dismissal of the entirety of the Claims Action with prejudice with the Delaware Court.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.5in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Good
Faith Cooperation</u>.</b></font></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&nbsp;Each
of the Parties agrees to cooperate in good faith to achieve the intent and spirit of this Agreement and to do all things appropriate
or necessary, including, but not limited to, executing any documents or taking any reasonable actions in a timely and expeditious manner,
in order to effectuate all of the terms and conditions of this Agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 1in"></td><td style="width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></font></td><td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Mutual
                                            General Releases Of Each Of The Parties</u>.</b></font></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&nbsp;For
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, 180 Life, on the one hand, and each of
the Krauss Parties, on the other hand, for themselves, and for each of their respective predecessors, affiliates, successors, heirs and
assigns, hereby fully and irrevocably releases, acquits and discharges each other, and all of their respective past, present and future
officers, directors, employees, agents, attorneys, representatives, principals, partners, joint venturers, affiliates, sureties, subsidiaries,
parent and affiliated corporations, predecessors, successors, heirs and assigns, and specifically including without limitation, KBL Healthcare
and each of the Third Party Defendants (collectively, the &ldquo;Related Persons&rdquo;), of and from any and all liabilities, claims,
defenses, causes of action, damages, costs (including costs of suit and attorneys&rsquo; fees and expenses), or demands of whatever nature,
character, type or description, whether known or unknown, existing or potential, anticipated or unanticipated, which any of the Parties
has or asserts, or may hereafter have or assert, against another Party, or against any of their respective Related Persons, by reason
of any act or omission on the part of another Party, or on the part of any of their respective Related Persons, occurring at any time
prior to the Effective Date of this Agreement, including without limitation, any and all liabilities, claims, defenses, causes of action,
damages, costs or demands which are embodied in, may arise out of, or are in any way connected with, any fact, matter or issue pertaining
to the Advancement Complaint, Amended Advancement Complaint, Claims Complaint, the Initial Counterclaims, the Amended Counterclaims,
the Advancement Order, the Undertaking, the Advance Payments, the Advancement Action and/or the Claims Action. Each of the Parties shall
bear their own respective attorneys&rsquo; fees and costs arising from or related to the Advancement Action and/or the Claims Action
and the preparation of this Agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&nbsp;The
general releases set forth in the foregoing paragraph shall be effective as of the Effective Date of this Agreement and shall extend
to all actual and/or potential liabilities, claims, defenses, causes of action, damages, costs or demands which may exist against the
Parties, or against any of their respective Related Persons, up to and including the Effective Date of this Agreement, regardless of
whether such liabilities, claims, defenses, causes of action, costs or demands are stated, alleged, or even suspected prior to such Effective
Date.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&nbsp;Notwithstanding
the provisions above, the general releases set forth in this Agreement are not intended to, and shall not extend to, or in any way release,
acquit or discharge, any of the rights, duties or obligations arising from, created by, or maintained by, this Agreement.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&nbsp;Each
of the Parties acknowledges that they may hereafter discover facts different from, or in addition to, those which they now believe to
be true with respect to any or all of the liabilities, claims, defenses, causes of action, damages, costs or demands herein released.
However, each of the Parties agrees that these general releases shall be, and shall remain, effective in all respects, notwithstanding
the discovery of such different or additional facts.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.&nbsp;As
of the Effective Date of this Agreement, each of the Parties shall be deemed to waive and relinquish, and do hereby expressly waive and
relinquish to the fullest extent permitted by law, any and all provisions, rights, and benefits conferred by any law of the United States
or any state or territory of the United States, including without limitation, Delaware and California, or principle of common law, which
governs or limits a person&rsquo;s release of unknown claims, including without limitation, California Civil Code Section 1542, and any
other law or principle which is similar, comparable or equivalent, and that was asserted or could have been asserted in the Advancement
Action and/or the Claims Action. California Civil Code Section 1542 provides as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;A
general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor
at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the
debtor or released party.&rdquo;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&nbsp;Each
of the Parties warrants and represents that they understand the effect and import of the provisions of section 1542 and/or that they
have been fully explained to them.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&nbsp;Each
of the Parties warrants and represents that none of the liabilities, claims, defenses, causes of action, damages, costs, or demands which
are intended to be released herein, as set forth above, has been assigned, in whole or in part, to any person or entity. To the extent
that the general releases set forth above run to the favor of persons or entities not signatories hereto, the Agreement is hereby declared
to be made in and for their respective benefits and uses.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: justify; width: 1in"></td><td style="text-align: justify; width: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Confidentiality
                                            Provision</u>.</b></font></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
Each of the Parties understands and expressly agrees that this Agreement, and each of the terms and provisions hereof, shall be, and
is intended to be, strictly confidential and shall not be disclosed by any of the Parties, or any of their respective agents, employees
and representatives, or any other person or entity acting in concert with them, to any person or entity, except as follows: (a)&nbsp;to
their respective agents, employees, representatives, attorneys, accountants, tax advisors and auditors; (b) as may be necessary to enforce
and/or interpret any of the provisions of this Agreement; (c) to a third party in connection with a potential financing, registration,
merger, acquisition, or related transaction, with confidentiality obligations no less restrictive than those in this Agreement; and/or
(d)&nbsp;in response to legal process or court order, or as otherwise may be required or compelled by law.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.5in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>G.</b></font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Mutual
Non-Disparagement</u>.</b></font></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&nbsp;Each
of the Parties covenants and agrees not to hereafter disparage, criticize, denigrate and/or otherwise make any negative comment or statement
in any manner about any of the other Parties, either in writing or orally, to any third person or entity, including without limitation,
by posting any such comment on any website, social media site, bulletin board and/or other internet site.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"></td><td style="width: 0.5in; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>H.</b></font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><u>Additional
Provisions</u>.</b></font></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&nbsp;Dr.
Krauss confirms and acknowledges to 180 Life that:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&nbsp;Dr.
Krauss will be acquiring the Subject Shares, for her own account, for investment purposes only and not with a view to, or for sale in
connection with, a distribution, as that term is used in Section 2(11) of the Securities Act of 1933, as amended (the &ldquo;Securities
Act&rdquo;), in a manner which would require registration under the Securities Act or any state securities laws. Dr. Krauss can bear
the economic risk of investment in the Subject Shares, has knowledge and experience in financial business matters, is capable of managing
the risk of investment in the Subject Shares and is an &ldquo;accredited investor&rdquo; as defined in Regulation D under the Securities
Act. Dr. Krauss recognizes that the Subject Shares have not been registered under the Securities Act, nor under the securities laws of
any state and, therefore, cannot be resold unless the resale of the Subject Shares is registered under the Securities Act or unless an
exemption from registration is available. Dr. Krauss has carefully considered and has, to the extent she believes such discussion necessary,
discussed with her professional, legal, tax and financial advisors, the suitability of an investment in the Subject Shares for her particular
tax and financial situation and her respective advisers, if such advisors were deemed necessary, have determined that the Subject Shares
are a suitable investment for her. Dr. Krauss has not been offered the Subject Shares by any form of general solicitation or advertising,
including, but not limited to, advertisements, articles, notices or other communications published in any newspaper, magazine, or other
similar media or television or radio broadcast or any seminar or meeting where, to Dr. Krauss&rsquo;s knowledge, those individuals that
have attended have been invited by any such or similar means of general solicitation or advertising. Dr. Krauss has had an opportunity
to ask questions of and receive satisfactory answers from 180 Life, or persons acting on behalf of 180 Life, concerning the terms and
conditions of the Subject Shares and 180 Life, and all such questions have been answered to the full satisfaction of Dr. Krauss. Neither
180 Life, nor any other party, has supplied Dr. Krauss any information regarding the Subject Shares or an investment in the Subject Shares
other than as contained in this Agreement, and Dr. Krauss is relying on her own investigation and evaluation of 180 Life and the Securities
and not on any other information.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&nbsp;Dr.
Krauss acknowledges that she is a sophisticated investor capable of assessing and assuming investment risks with respect to securities,
including securities such as the Subject Shares, and further acknowledges that 180 Life is entering into this Agreement with Dr. Krauss
in reliance on this acknowledgment and with Dr. Krauss&rsquo;s understanding, acknowledgment and agreement that 180 Life is privy to
material non-public information regarding 180 Life (collectively, the &ldquo;Non-Public Information&rdquo;), which Non- Public Information
may be material to a reasonable investor, such as Dr. Krauss, when making investment disposition decisions, including the decision to
enter into this Agreement, and Dr. Krauss&rsquo;s decision to enter into the Agreement is being made with full recognition and acknowledgment
that 180 Life is privy to the Non-Public Information, irrespective of whether such Non-Public Information has been provided to Dr. Krauss.
Dr. Krauss hereby waives any claim, or potential claim, she has or may have against 180 Life relating to 180 Life&rsquo;s possession
of Non-Public Information. Dr. Krauss has specifically requested that 180 Life not provide her with any Non-Public Information. Dr. Krauss
understands and acknowledges that 180 Life would not enter into this Agreement in the absence of the representations and warranties set
forth in this paragraph, and that these representations and warranties are a fundamental inducement to 180 Life in entering into this
Agreement; and</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)&nbsp;Dr.
Krauss understands and agrees that a legend has been or will be placed on any certificate(s) or other document(s) evidencing the Subject
Shares in substantially the following form:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES
ACT. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS (I) THEY SHALL
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND ANY APPLICABLE STATE SECURITIES ACT, OR (II) THE CORPORATION SHALL
HAVE BEEN FURNISHED WITH AN OPINION OF COUNSEL, SATISFACTORY TO COUNSEL FOR THE CORPORATION, THAT REGISTRATION IS NOT REQUIRED UNDER
ANY SUCH ACTS.&rdquo;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.&nbsp;Each
of the Parties denies any liability to each of the other Parties, and acknowledges and agrees that the execution and delivery of this
Agreement by the Parties constitutes a settlement of disputed and contested claims, and that no provision hereof or act taken pursuant
hereto shall constitute or be construed as an admission of any liability or wrongdoing on the part of any of the Parties.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.&nbsp;Each
of the Parties acknowledges that, but for the provision of each of the Recitals and terms of this Agreement, none of the Parties would
enter into this Agreement. No addition, modification, amendment or waiver of any part of this Agreement shall be binding or enforceable
unless executed in writing by each of the Parties.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
This Agreement shall be construed as if mutually prepared by each of the Parties, and shall be interpreted and governed in accordance
with the laws of the State of California.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.&nbsp;This
Agreement is executed voluntarily by each of the Parties, without any duress or undue influence on the part of, or on behalf of, any
of them. Each of the Parties has read and fully understands the provisions of this Agreement and has relied upon and/or had the opportunity
to rely upon the advice and representation of legal counsel in entering into this Agreement.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.&nbsp;If
any portion of this Agreement is declared by a court of competent jurisdiction to be invalid or unenforceable, such portion shall be
deemed severed from the Agreement, and the remaining part shall remain in full force and effect as if no such invalid or unenforceable
provision had been a part of the Agreement.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
This Agreement represents the entire agreement between the Parties with respect to the matters referred to herein, and supersedes any
and all previous understandings, representations and agreements between the Parties, whether written or oral.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.&nbsp;This
Agreement shall bind, and inure to the benefit of, the respective successors, assigns, transferees, grantees, beneficiaries, legatees,
heirs, executors, administrators, and estates of each of the Parties.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.&nbsp;This
Agreement may be executed in multiple counterparts, each of which when taken together shall constitute one and the same instrument. This
Agreement may be executed and transmitted by e-mail and/or facsimile, and all executed e-mail and/or facsimile copies shall be deemed
and accepted as signed originals.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.&nbsp;This
Agreement shall be effective upon execution this Agreement by all Parties, which date shall be known as the &ldquo;Effective Date&rdquo;
of the Agreement.</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, each of the Parties has executed this Agreement by his/her/its signature or the signature of its authorized representative
as set forth below.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED: <u style="text-decoration: none">February 21, 2025</u></font></td>
    <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">180 LIFE SCIENCES CORP.</font></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 6%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 34%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Blair Jordan&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name):</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blair
Jordan</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br >
</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 60%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED: <u style="text-decoration: none">2-21-25</u></font></td>
    <td style="border-bottom: Black 1.5pt solid; width: 40%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Marlene Krauss</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARLENE
    KRAUSS</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATED: <u style="text-decoration: none">2-21-25</u></font></td>
    <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KBL IV SPONSOR, LLC</font></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 6%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 34%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1.5pt solid"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Marlene Krauss</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name):</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marlene Krauss</font></td></tr>
  <tr style="vertical-align: top">
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</font></td>
    <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Member</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea023200801ex10-2_180life.htm
<DESCRIPTION>VOTING AGREEMENT DATED FEBRUARY 21, 2025, BETWEEN 180 LIFE SCIENCES CORP., DR. MARLENE KRAUSS AND BLAIR JORDAN
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Exhibit 10.2</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VOTING AGREEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>THIS VOTING AGREEMENT</b>,
dated and effective February 21, 2025 (this &ldquo;<b><u>Agreement</u></b>&rdquo;), is made by and among Blair Jordan, an individual (&ldquo;<b><u>Jordan</u></b>&rdquo;)
and Dr. Marlene Krauss, an individual (the &ldquo;<b><u>Securityholder</u></b>&rdquo;); and 180 Life Sciences Corp. (the &ldquo;<b><u>Company</u></b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RECITALS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>WHEREAS</b>, the Securityholder
holds 200,000 shares of the common stock of the <b><u>Company</u></b> (the &ldquo;<b><u>Shares</u></b>&rdquo;); and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>WHEREAS</b>, the Securityholder
desires to enter into this Agreement to provide Jordan, the interim Chief Executive Officer of the Company, voting rights to the Shares,
for the benefit of the Company, on the terms and pursuant to the conditions set forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, in consideration
of the mutual representations, warranties, covenants and agreements set forth herein, for $10, the receipt and sufficiency of which Securityholder
acknowledges from the Company, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties to this Agreement, intending to be legally bound, agree as follows:</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif">ARTICLE
I.</font><br >
SHARES; AGREEMENT TO VOTE AND VOTING PROXY</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">1.1.&nbsp;</font><u>Agreement
to Vote Shares</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif">1.1.1&nbsp;</font>During
the Term of this Agreement, Securityholder agrees to vote all shares which she owns (the &ldquo;<b><u>Shares</u></b>&rdquo;), in such
manner as may be necessary to approve all proposals sought to be approved at any meeting of the stockholders of the Company, which are
approved by the Board of Directors, and recommended to be approved by at least a majority of the members of the Board of Directors of
the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif">1.1.2&nbsp;</font>The
voting requirements set forth in this <u>Section 1.1</u> shall be defined herein as the &ldquo;<b><u>Voting Requirements</u></b>&rdquo;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">1.2.&nbsp;</font><u>Irrevocable
Proxy and Power of Attorney</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif">1.2.1&#9;</font>Securityholder,
by her entry into this Agreement, hereby constitutes and appoints Jordan, with the power to act alone and with full power of substitution,
during and for the Term, for the benefit of the Company, as Securityholder&rsquo;s true and lawful attorney and irrevocable proxy, for
and in the Securityholder&rsquo;s name, place and stead, to vote or act by written consent with respect to the Shares owned or held by
Securityholder as Securityholder&rsquo;s proxy, solely in connection with the Voting Requirements, and to execute all appropriate instruments
consistent with this Agreement on behalf of Securityholder, in all proceedings in which the vote or written consent of the Securityholder
may be required or authorized by law during the Term (including, but not limited to actual meetings of the stockholders of the Company
and written consents to action) regardless of whether such Securityholder actually attends any applicable meeting or signs any applicable
consent, or not (the &ldquo;<b><u>Proxy</u></b>&rdquo;). Without limiting the foregoing, Securityholder shall deliver to Jordan a duly
executed Irrevocable Voting Proxy in the form of <b><u>Exhibit A</u></b> hereto, which shall be irrevocable to the fullest extent permissible
by law, in the form attached hereto simultaneously with the execution hereof.&#9;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><font style="font-family: Times New Roman, Times, Serif">1.2.2&nbsp;</font>The
proxy and power granted by Securityholder pursuant to this Section are coupled with an interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b></b>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 3</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Voting Agreement</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">1.3.&nbsp;</font><u>Termination</u>.
The provisions of this Agreement shall terminate automatically upon the earlier of (a) August 21, 2025, and (b) the date that the Company
has provided written notice to Securityholder of the termination of this Agreement (the &ldquo;<b><u>Term</u></b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">1.4.&nbsp;</font><u>Reservation
of Rights</u>. All other rights and privileges of ownership of the Shares shall be reserved to and retained by the Securityholder, except
to the extent expressly set forth herein.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif">ARTICLE
II.</font><br >
TRANSFERS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">2.1.&nbsp;</font><u>General
Restrictions</u>. Securityholder agrees that during the Term, Securityholder shall not, and shall not permit anyone else to, (i) sell,
transfer, encumber, pledge, assign or otherwise dispose of any of the Shares, (ii) deposit the Shares into a voting trust or enter into
a voting agreement or arrangement with respect to the Shares or grant any proxy or power of attorney with respect thereto, or (iii) enter
into any contract, option or other legally binding undertaking providing for any transaction provided in (i) or (ii) hereof (each a &ldquo;<b><u>Transfer</u></b>&rdquo;),
without the prior written consent of the Company. Any Transfer not in accordance with this <u>Section 2.1</u> shall be deemed to constitute
a Transfer by Securityholder in violation of this Agreement, shall be void&nbsp;<i>ab initio</i>, and the Company shall not recognize
any such Transfer.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif">ARTICLE
III.</font><br >
GENERAL PROVISIONS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">3.1.&nbsp;</font><u>Entire
Agreement</u>. This Agreement (including the exhibits and schedules hereto and thereto) contains all of the terms, conditions and representations
and warranties agreed to by the parties relating to the subject matter of this Agreement and supersedes all prior or contemporaneous agreements,
negotiations, correspondence, undertakings, understandings, representations and warranties, both written and oral, among the parties to
this Agreement with respect to the subject matter of this Agreement. No representation, warranty, inducement, promise, understanding or
condition not set forth in this Agreement has been made or relied upon by any of the parties to this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">3.2.&nbsp;</font><u>Governing
Law</u>. This Agreement and any claim, controversy or dispute arising under or related thereto, the relationship of the parties, and/or
the interpretation and enforcement of the rights and duties of the parties, whether arising in law or in equity, in contract, tort or
otherwise, shall be governed by, and construed and interpreted in accordance with, the laws of the State of Delaware without regard to
its rules regarding conflicts of law to the extent that the application of the laws of another jurisdiction would be required thereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif">3.3.&nbsp;</font><u>Counterparts</u>.
This Agreement and any signed agreement or instrument entered into in connection with this Agreement, and any amendments hereto or thereto,
may be executed in one or more counterparts, all of which shall constitute one and the same instrument. Any such counterpart, to the extent
delivered by means of a facsimile machine or by .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail (any such delivery, an
&ldquo;<b><u>Electronic Delivery</u></b>&rdquo;) shall be treated in all manner and respects as an original executed counterpart and shall
be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request
of any party, each other party shall re-execute the original form of this Agreement and deliver such form to all other parties. No party
shall raise the use of Electronic Delivery to deliver a signature or the fact that any signature or agreement or instrument was transmitted
or communicated through the use of Electronic Delivery as a defense to the formation of a contract, and each such party forever waives
any such defense, except to the extent such defense relates to lack of authenticity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature page follows.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b></b>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> of 3</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Voting Agreement</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>IN WITNESS WHEREOF</b>,
this Agreement has been duly executed and delivered by the parties to this Agreement as of the date first written above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2">&ldquo;<b><u>Jordan</u></b>&rdquo;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&nbsp;</td>
    <td style="width: 5%">&nbsp;</td>
    <td style="text-align: justify; width: 35%">&nbsp;</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Blair Jordan</td>
    </tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="text-align: justify"><b>Blair Jordan</b></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: 0.5in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify; text-indent: 0.5in"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify"><b>&ldquo;<u>Securityholder</u>&rdquo;</b></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 5%">&nbsp;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%">/s/ Marlene Krauss</td>
    <td style="width: 60%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><b>Dr. Marlene Krauss</b></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: left"><b>&ldquo;<u>Company</u>&rdquo;</b></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: center">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify"><b>180 Life Sciences, Inc.</b></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify">&nbsp;</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Blair Jordan</td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><b>Blair Jordan</b></td>
    <td>&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&nbsp;</td>
    <td style="text-align: justify"><b>Chief Executive Officer</b></td>
    <td>&nbsp;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b></b>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> of 3</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Voting Agreement</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
A</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.125in; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>IRREVOCABLE VOTING PROXY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dr. Marlene Krauss, an individual
(&ldquo;<b><u>Securityholder</u></b>&rdquo;), who beneficially owns 200,000 shares of the common stock of 180 Life Sciences Corp., a Delaware
corporation (the &ldquo;<b><u>Company</u></b>&rdquo; and the &ldquo;<b><u>Shares</u></b>&rdquo;, which term shall include such other shares
as <font style="font-size: 10pt">it</font> may come to own or have voting control over, as described in greater detail in the Voting Agreement,
dated <font style="font-size: 10pt">February 21</font>, 2025, to which this Irrevocable Voting Proxy is attached to as <u>Exhibit&nbsp;A</u>)(the
&ldquo;<b><u>Agreement</u></b>&rdquo;), of the Company as of the date hereof, hereby appoints Blair Jordan, an individual, as her proxy
(the &ldquo;<b><u>Proxy</u></b>&rdquo;), with the power to act alone and with full power of substitution, during and for the Term, as
Securityholder&rsquo;s true and lawful attorney and irrevocable proxy, for and in the Securityholder&rsquo;s name, place and stead, to
vote or act by written consent with respect to the Shares owned or held by Securityholder as Securityholder&rsquo;s proxy, and to execute
all appropriate instruments consistent with this Irrevocable Voting Proxy on behalf of Securityholder, in all proceedings in which the
vote or written consent of the stockholders may be required or authorized by law during the Term (including, but not limited to actual
meetings of the stockholders of the Company and written consents to action) regardless of whether Securityholder actually attends any
applicable meeting or signs any applicable consent, or not, as if the undersigned were present and voting such Shares, in connection with
the Voting Requirements (as defined in the Agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon Securityholder&rsquo;s
execution of this Irrevocable Voting Proxy, any and all prior proxies (other than this Irrevocable Voting Proxy) given by Securityholder
with respect to the subject matter contemplated by this Irrevocable Voting Proxy are hereby revoked with respect to such subject matter
and Securityholder agrees not to grant any subsequent proxies with respect to such subject matter or enter into any agreement or understanding
with any person to vote or give instructions with respect to such subject matter in any manner inconsistent with the terms of this Irrevocable
Voting Proxy until after the expiration of the Term (as defined below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Proxy named above, and
his assigns, are hereby authorized and empowered by Securityholder, at any time prior to the end of the Term, to act as Securityholder&rsquo;s
attorney and proxy to vote the Shares, and to exercise all voting and other rights of Securityholder with respect to the Shares (including,
without limitation, the power to execute and deliver written consents pursuant to the Delaware General Corporation Law (or such law applicable
to the Company&rsquo;s then jurisdiction of organization)), at every annual, special or adjourned meeting of the stockholders of the Company
and in every written consent in lieu of such meeting. The undersigned hereby affirms that this Irrevocable Voting Proxy, <font style="background-color: white">which
shall be irrevocable to the fullest extent permissible by law,</font> is coupled with an interest and ratifies and confirms all that the
Proxy may lawfully do or cause to be done by virtue hereof. This Irrevocable Voting Proxy shall terminate at the end of the Term of the
Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All authority herein conferred
shall be binding upon the heirs, representatives, successors and assigns of Securityholder. Executed this 21st <font style="font-size: 10pt">day
of February 2025</font>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&nbsp;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2"><b>&ldquo;<u>Securityholder</u>&rdquo;</b> </td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 5%">&nbsp;</td>
    <td style="text-align: justify; width: 35%">&nbsp;</td>
    <td style="text-align: justify; width: 60%">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: justify">/s/ Marlene Krauss</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  <tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td style="text-align: justify">Dr. Marlene Krauss</td>
    <td style="text-align: justify">&nbsp;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</p>

<!-- Field: Page; Sequence: 5; Options: NewSection Last -->
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b></b>Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> of 1</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Joinder to Voting Agreement</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>atnf-20250221.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aBZo7xRiXgen8uEb3JcWayPWcPtzpR3ielBtmpybckqHyMsP1LYXi82zG7m8d8K -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ATNF="http://180lifesciencescorp.com/20250221" elementFormDefault="qualified" targetNamespace="http://180lifesciencescorp.com/20250221">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://180lifesciencescorp.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20250221_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20250221_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atnf-20250221_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="ATNF_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" name="WarrantsToPurchaseSharesOfCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>atnf-20250221_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://180lifesciencescorp.com/role/Cover" xlink:href="atnf-20250221.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://180lifesciencescorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250221.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="loc_ATNFCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250221.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>atnf-20250221_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="atnf-20250221.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="ATNF_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATNF_CommonStockParValue0.0001PerShareMember" xlink:to="ATNF_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATNF_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="atnf-20250221.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:to="ATNF_WarrantsToPurchaseSharesOfCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ATNF_WarrantsToPurchaseSharesOfCommonStockMember_lbl" xml:lang="en-US">Warrants to purchase shares of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>atnf-20250221_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://180lifesciencescorp.com/role/Cover" xlink:href="atnf-20250221.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://180lifesciencescorp.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250221.xsd#ATNF_CommonStockParValue0.0001PerShareMember" xlink:label="loc_ATNFCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="atnf-20250221.xsd#ATNF_WarrantsToPurchaseSharesOfCommonStockMember" xlink:label="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ATNFWarrantsToPurchaseSharesOfCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45089887151280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 21, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 21,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">180 LIFE SCIENCES CORP.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001690080<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-1890354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3000 El Camino Real<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">&#160;Bldg. 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">&#160;Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">507-0669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATNF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember', window );">Warrants to purchase shares of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase shares of Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATNFW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATNF_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ATNF_WarrantsToPurchaseSharesOfCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M<C=T7.?MPJ/8;(V]T!P-4K;A/C=_I@L%9\U")10Q3[20"5%\/73&[O5-B]J
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( .Z!65JJQ"(6,P$  "("   /
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .Z!65HD'INBK0   /@!   :
M          "  2(2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( .Z!65IED'F2&0$  ,\#   3              "  0<3  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  %$4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea023200801-8k_180life.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://180lifesciencescorp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>atnf-20250221.xsd</File>
    <File>atnf-20250221_def.xml</File>
    <File>atnf-20250221_lab.xml</File>
    <File>atnf-20250221_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea023200801-8k_180life.htm">ea023200801-8k_180life.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea023200801-8k_180life.htm": {
   "nsprefix": "ATNF",
   "nsuri": "http://180lifesciencescorp.com/20250221",
   "dts": {
    "schema": {
     "local": [
      "atnf-20250221.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "atnf-20250221_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "atnf-20250221_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atnf-20250221_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea023200801-8k_180life.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://180lifesciencescorp.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-21",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea023200801-8k_180life.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-21",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea023200801-8k_180life.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "auth_ref": []
    },
    "ATNF_CommonStockParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://180lifesciencescorp.com/20250221",
     "localname": "CommonStockParValue0.0001PerShareMember",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ATNF_WarrantsToPurchaseSharesOfCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://180lifesciencescorp.com/20250221",
     "localname": "WarrantsToPurchaseSharesOfCommonStockMember",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase shares of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://180lifesciencescorp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001213900-25-017089-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-25-017089-xbrl.zip
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MLBNX6ZH4%4;?R&&BV!0[4^JC_C)>BF,UP,,H_V^072_+!US^ U!+ P04
M" #N@5E:BIW$ZP0)  "=:   %0   &%T;F8M,C R-3 R,C%?9&5F+GAM;-5=
M77/;-A9][\S^!Z[Z+.O#\6[CQNTHBM71-(E=2TVZ??% )"1A# $> +2E?[\
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MKY-;G:%N.(M:OT8B2@S[)^8J?8W%;(T$_I),#PONF.(U2[^"7_FY*^!%R;G
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MO?%L@RC]&$H=@"P=?W+ %@A>Y L*[G1%\>4&BY4>!G\3_%&MDXV\9<);"[3
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MT[7X)#87F\1?,YP2L>7_4$L#!!0    ( .Z!65H.-O/=3 @  #=C   5
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M@4\1PEFA"4<Q'^37C)7RCA6H*N'L5%>"!HYY:48T#-9FAC E\1[][H$I)E1
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M67 4"QS1@VLL$-G?3*%NJ &QGV4V]$LP]B[$<+;CK[8]?/[?5ZHUV/ ;*]9
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M+HR;<BK#?\J%1CT>TZP\/WO6"HGV2.V4O]G2B;5T98P_NU9/S?X74$L#!!0
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MA,X!LR>PG$AG"E:6T3R>P6K3T4B#O&Y04B^)-L@<>DNA$+$5H(01MEL'@+4
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M[71?.IF;)S66 =J\B"O^[]V\5(U/J_HNTJOE)3W+,_P'4>@6CP7]NX.;M'!
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ML>K2<J+<(V G]V<A.[^ PGVZ8LMK(H4>B0DEJH#^RT7BV9G=L,/5THI#56;
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M.34P%??7$Z(9E]?>)+J"A1IN# S[&+CT2KPI:D<Y4J&]5OP5.;^>O#U0PZS
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F,3 M,E\Q.#!L:69E+FAT;5!+!08     !P ' .8!  "U<@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ea023200801-8k_180life_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ATNF="http://180lifesciencescorp.com/20250221"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atnf-20250221.xsd" xlink:type="simple"/>
    <context id="AsOf2025-02-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
        </entity>
        <period>
            <startDate>2025-02-21</startDate>
            <endDate>2025-02-21</endDate>
        </period>
    </context>
    <context id="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-21</startDate>
            <endDate>2025-02-21</endDate>
        </period>
    </context>
    <context id="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001690080</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ATNF:WarrantsToPurchaseSharesOfCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-21</startDate>
            <endDate>2025-02-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-02-21" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-02-21" id="Fact000004">0001690080</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-02-21" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-02-21" id="Fact000010">2025-02-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-02-21" id="Fact000011">180 LIFE SCIENCES CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-02-21" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-02-21" id="Fact000013">001-38105</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-02-21" id="Fact000014">90-1890354</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-02-21" id="Fact000015">3000 El Camino Real</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-02-21" id="Fact000016">&#160;Bldg. 4</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="AsOf2025-02-21" id="Fact000017">&#160;Suite 200</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-02-21" id="Fact000018">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-02-21" id="Fact000019">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-02-21" id="Fact000020">94306</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-02-21" id="Fact000021">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-02-21" id="Fact000022">507-0669</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-02-21" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-02-21" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-02-21" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-02-21" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000027">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000028">ATNF</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-212025-02-21_custom_CommonStockParValue0.0001PerShareMember"
      id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="Fact000030">Warrants to purchase shares of Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="Fact000031">ATNFW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-02-212025-02-21_custom_WarrantsToPurchaseSharesOfCommonStockMember"
      id="Fact000032">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-02-21" id="Fact000033">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
